01 2ACETAMINOPHEN; BUTALBITAL
02 1ACETAMINOPHEN; BUTALBITAL; CAFFEINE
03 7ACETAMINOPHEN; HYDROCODONE BITARTRATE
04 3ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE
05 2ACETYLCYSTEINE
06 7AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE
07 2BOSENTAN
08 5BUPRENORPHINE
09 4BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
10 1CARBIDOPA
11 1CICLOPIROX
12 1CITALOPRAM HYDROBROMIDE
13 2DAPSONE
14 4DEXAMETHASONE
15 1DISULFIRAM
16 1ECONAZOLE NITRATE
17 1ETHACRYNIC ACID
18 1EXEMESTANE
19 2FELBAMATE
20 4FLECAINIDE ACETATE
21 5FLUOCINONIDE
22 5GABAPENTIN
23 3HYDROCHLOROTHIAZIDE; LISINOPRIL
24 13HYDROCODONE BITARTRATE
25 6IBRUTINIB
26 4LABETALOL HYDROCHLORIDE
27 1LEVONORGESTREL
28 12LEVOTHYROXINE SODIUM
29 7LISDEXAMFETAMINE DIMESYLATE
30 4LORAZEPAM
31 1MELPHALAN
32 1METHENAMINE HIPPURATE
33 9METHYLPHENIDATE HYDROCHLORIDE
34 3MINOCYCLINE HYDROCHLORIDE
35 2NATEGLINIDE
36 2NEVIRAPINE
37 3NIFEDIPINE
38 3NITROFURANTOIN, MACROCRYSTALLINE
39 2NITROFURANTOIN; NITROFURANTOIN, MACROCRYSTALLINE
40 2OFLOXACIN
41 1OSELTAMIVIR PHOSPHATE
42 3OXYCODONE HYDROCHLORIDE
43 6PREGABALIN
44 1PRIMAQUINE PHOSPHATE
45 1PYRIDOSTIGMINE BROMIDE
46 1PYRIMETHAMINE
47 2RIFAXIMIN
48 3RIVASTIGMINE
49 2SERTRALINE HYDROCHLORIDE
50 1SODIUM PHENYLBUTYRATE
51 1TERIPARATIDE
52 1TOLCAPONE
53 2TRAZODONE HYDROCHLORIDE
54 1VENLAFAXINE BESYLATE
55 1ZOLPIDEM TARTRATE
56 2capecitabine
01 21ALMATICA
02 126ALVOGEN
03 2ALVOGEN INC
04 6ALVOGEN PINE BROOK
05 2Alvogen IPCO S.ar.l,
06 11NORWICH
07 1NORWICH PHARMACEUTICALS INC
01 10CAPSULE, EXTENDED RELEASE;ORAL
02 21CAPSULE;ORAL
03 3CREAM;TOPICAL
04 2FILM COATED PILL
05 8FILM, EXTENDED RELEASE;TRANSDERMAL
06 4FILM;BUCCAL, SUBLINGUAL
07 1FOR SUSPENSION;ORAL
08 2GEL;TOPICAL
09 1OINTMENT;TOPICAL
10 1SOLUTION/DROPS;OPHTHALMIC
11 1SOLUTION/DROPS;OTIC
12 2SOLUTION;INHALATION, ORAL
13 1SOLUTION;SUBCUTANEOUS
14 1SOLUTION;TOPICAL
15 26TABLET, EXTENDED RELEASE;ORAL
16 85TABLET;ORAL
01 10.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
02 50.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
03 10.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
04 10.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
05 10.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
06 10.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
07 10.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
08 10.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
09 10.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
10 10.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
11 10.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
12 10.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
13 20.3%
14 10.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
15 10.56MG/2.24ML (0.25MG/ML)
16 10.5MG
17 10.75MG
18 10.77% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
19 11% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
20 11.25MG;1.25MG;1.25MG;1.25MG
21 21.5MG
22 11.875MG;1.875MG;1.875MG;1.875MG
23 110%
24 6100MG
25 2100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
26 110MCG/HR
27 410MG
28 112.5MG;10MG
29 112.5MG;20MG
30 2120MG
31 1125MG
32 113.3MG/24HR
33 2140MG
34 1150 MG
35 1150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
36 115MCG/HR
37 215MG
38 2165MG
39 1180MG
40 118MG
41 11GM
42 11MG
43 12.5MG;2.5MG;2.5MG;2.5MG
44 120%
45 1200MG
46 2200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
47 120MCG/HR
48 520MG
49 1250MG
50 625MG
51 125MG;20MG
52 127MG
53 1280MG
54 22MG
55 13.125MG;3.125MG;3.125MG;3.125MG
56 13.75MG;3.75MG;3.75MG;3.75MG
57 1300MG
58 1300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
59 1300MG;10MG
60 1300MG;50MG
61 1300MG;5MG
62 1300MG;7.5MG
63 430MG
64 130MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
65 2325MG;10MG
66 1325MG;2.5MG
67 1325MG;50MG
68 1325MG;50MG;40MG
69 2325MG;5MG
70 2325MG;7.5MG
71 2330MG
72 136MG
73 13MG
74 14.6MG/24HR
75 2400MG
76 1400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
77 340MG
78 1420MG
79 1450MG
80 14MG
81 1500 MG
82 1500MG
83 450MG
84 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
85 154MG
86 1550MG
87 1560MG
88 15MCG/HR
89 25MG
90 15MG;5MG;5MG;5MG
91 2600MG
92 360MG
93 160MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
94 162.5MG
95 16MG
96 17.5MCG/HR
97 17.5MG
98 17.5MG;7.5MG;7.5MG;7.5MG
99 270MG
100 1750MG
101 275MG;25MG
102 180MG
103 282.5MG
104 19.5MG/24HR
105 1900MG
106 190MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
107 1EQ 100MG BASE
108 1EQ 112.5MG BASE
109 1EQ 12MG BASE;EQ 3MG BASE
110 1EQ 150MG BASE
111 1EQ 15MG BASE
112 1EQ 200MG BASE
113 1EQ 2MG BASE;EQ 0.5MG BASE
114 1EQ 30MG BASE
115 1EQ 4MG BASE;EQ 1MG BASE
116 1EQ 50MG BASE
117 1EQ 6MG BASE/ML
118 1EQ 75MG BASE
119 1EQ 8MG BASE;EQ 2MG BASE
01 2Sweden
02 167USA
Regulatory Info : DISCN
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : BUTALBITAL AND ACETAMINOP...
Dosage Strength : 325MG;50MG
Packaging :
Approval Date : 2015-10-30
Application Number : 205120
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : BUTALBITAL AND ACETAMINOP...
Dosage Strength : 300MG;50MG
Packaging :
Approval Date : 2017-06-05
Application Number : 207635
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
ACETAMINOPHEN; BUTALBITAL; CAFFEINE
Dosage Form : TABLET;ORAL
Brand Name : BUTALBITAL, ACETAMINOPHEN...
Dosage Strength : 325MG;50MG;40MG
Packaging :
Approval Date : 2017-01-10
Application Number : 204984
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
ACETAMINOPHEN; HYDROCODONE BITARTRATE
Dosage Form : TABLET;ORAL
Brand Name : HYDROCODONE BITARTRATE AN...
Dosage Strength : 300MG;5MG
Packaging :
Approval Date : 2018-11-08
Application Number : 208540
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
ACETAMINOPHEN; HYDROCODONE BITARTRATE
Dosage Form : TABLET;ORAL
Brand Name : HYDROCODONE BITARTRATE AN...
Dosage Strength : 300MG;7.5MG
Packaging :
Approval Date : 2018-11-08
Application Number : 208540
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
ACETAMINOPHEN; HYDROCODONE BITARTRATE
Dosage Form : TABLET;ORAL
Brand Name : HYDROCODONE BITARTRATE AN...
Dosage Strength : 300MG;10MG
Packaging :
Approval Date : 2018-11-08
Application Number : 208540
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
ACETAMINOPHEN; HYDROCODONE BITARTRATE
Dosage Form : TABLET;ORAL
Brand Name : HYDROCODONE BITARTRATE AN...
Dosage Strength : 325MG;2.5MG
Packaging :
Approval Date : 2018-10-24
Application Number : 209958
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
ACETAMINOPHEN; HYDROCODONE BITARTRATE
Dosage Form : TABLET;ORAL
Brand Name : HYDROCODONE BITARTRATE AN...
Dosage Strength : 325MG;5MG
Packaging :
Approval Date : 2018-10-24
Application Number : 209958
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
ACETAMINOPHEN; HYDROCODONE BITARTRATE
Dosage Form : TABLET;ORAL
Brand Name : HYDROCODONE BITARTRATE AN...
Dosage Strength : 325MG;7.5MG
Packaging :
Approval Date : 2018-10-24
Application Number : 209958
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
ACETAMINOPHEN; HYDROCODONE BITARTRATE
Dosage Form : TABLET;ORAL
Brand Name : HYDROCODONE BITARTRATE AN...
Dosage Strength : 325MG;10MG
Packaging :
Approval Date : 2018-10-24
Application Number : 209958
Regulatory Info : DISCN
Registration Country : USA
Alvogen is a supplier offers 2 products (APIs, Excipients or Intermediates).
Find a price of Furaltadone HCl bulk offered by Alvogen
Find a price of Mesalazine bulk offered by Alvogen
